Sort
51,593 grants matching “hepatitis”
Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
$595,276Patrick Robert Griffin · University Of California, San Diego · U19 · FY2012 · DA
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y Homozygotes
$595,249Christine E McLaren · University Of California-Irvine · R24 · FY2014 · DK
Lymphatics in the liver
$595,209Yasuko Iwakiri · Yale University · R01 · FY2025 · DK
The role of hexokinase 2 in liver fibrosis and NASH-induced HCC
$595,149Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA
Unlocking the Potential of PI3K Inhibition in CLL
$595,146Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Copper Homeostasis and Liver Function
$595,143Svetlana Lutsenko · Johns Hopkins University · R01 · FY2024 · DK
Regulation of HNF4 in Hepatic Failure in Cirrhosis
$595,100Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · DK
Regulation of HNF4 in Hepatic Failure in Cirrhosis
$595,100Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · DK
Regulation of HNF4 in Hepatic Failure in Cirrhosis
$595,100Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · DK
Regulation of HNF4 in Hepatic Failure in Cirrhosis
$595,100Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · DK
Hereditary Genetics of Hepatocellular Carcinoma
$595,097Kirk J Wangensteen · Mayo Clinic Rochester · R37 · FY2024 · CA
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans
$595,095Toni I. Pollin · University Of Maryland Baltimore · R01 · FY2014 · HL
National HIV Behavioral Surveillance System
$595,002Alan Neaigus · New York City Health/Mental Hygiene · U1B · FY2011 · PS
Metabolic Markers and Predictors of Childhood Obesity
$594,925Sonia Caprio · Yale University · R01 · FY2023 · HD
Increasing HCV Knowledge &Service Use in Drug Tx Pgms
$594,913National Development &Res Institutes · R01 · FY2005 · DA
PD-1 modulation of SIV specific CD4 and CD8 T cell responses
$594,813Francois J Villinger · Emory University · R01 · FY2011 · AI
Lipotoxicity and Maintenance of Metabolic Health
$594,765Jean E Schaffer · Joslin Diabetes Center · R01 · FY2025 · DK
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care
$594,712Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2016 · DA
Multiepitope circumsporozoite P.falciparum malaria subunit vaccine displayed on v
$594,705David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2009 · AI
Core--Laboratory and Data Management
$594,659Ernst John Schaefer · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
Hepatocyte-derived extracellular vesicles in alcoholic liver disease
$594,593Ariel Feldstein · University Of California, San Diego · R01 · FY2020 · AA
A Novel Nanodrug for Metabolic Disease Treatment
$594,547Yu-Jui Yvonne Wan · University Of California At Davis · R56 · FY2024 · DK
Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy
$594,457Charles H Hinkin · Brentwood Biomedical Research Institute · R01 · FY2011 · MH
HIV/HCV Co-infection: HAART and CVD Pathophysiology
$594,404University Of Miami Coral Gables · R01 · FY2004 · HL
The impact of prenatal exposure to persistent organic pollutants on kinetics of immune response to vaccines and sero-protection in infants
$594,365Parveen Bhatti · Fred Hutchinson Cancer Research Center · R01 · FY2019 · ES